Clinical Trial

Study on the Health Economic Burden of Alzheimer's Disease in China

Name: Study on the Health Economic Burden of Alzheimer's Disease in China — clinical trial record (NCT05995418)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.

Trial Details

NCT Number	NCT05995418
Lead Sponsor	Xuanwu Hospital, Beijing
Conditions	Alzheimer Disease
Enrollment	9,510 participants
Start Date	2023-07-01
Primary Completion	2026-06-30 (estimated)
Study Completion	2027-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-05